Table 4.
Adverse effects.
| Group NF (n = 39) | Group N240 (n = 39) | p Value | |
|---|---|---|---|
| PONV * | 6 (15.4) | 4 (10.3) | 0.737 |
| HTN | 0 (0) | 1 (2.6) | 1.000 |
| Dizziness | 2 (5.1) | 0 (0) | 0.494 |
| Tachycardia | 0 (0) | 1 (2.6) | 1.000 |
| Respiratory depression | 0 (0) | 1 (2.6) | 1.000 |
| Total | 6 (15.4) | 6 (15.4) | 1.000 |
Values are expressed as the number (percentage) of patients [n (%)]. Group NF, group receiving nefopam-fentanyl polytherapy; Group N240, group receiving nefopam monotherapy; HTN, hypertension; PONV, postoperative nausea and vomiting. *: number (percentage) of patients who experienced PONV with NRS score >0.